Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This article describes a methodology for the isolation, characterization, and quantification of human plasma-derived extracellular vesicles (EV) and presents a workflow for label-free analysis of the EV proteome using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Abstract

Extracellular vesicles (EV) are cell-derived, lipid bilayer-enclosed, non-replicable nanoparticles. EV currently gain attention in cardiovascular research due to their role in regulating intercellular communication, potentially serving as valuable biomarkers for cardiovascular disease. However, the EV proteome and its potential as a biomarker in cardiovascular diagnostics remain poorly understood. This protocol presents a standardized method for the isolation and quantification of plasma-derived EV and the analysis of their protein cargo using plasma samples from patients presenting to the Chest Pain Unit of a large university hospital. Following routine phlebotomy, EV are isolated from plasma by differential ultracentrifugation. The enrichment of specific EV marker proteins in EV isolates is visualized by immunoblotting, and average size distribution and plasma EV concentrations are quantified by nanoparticle tracking analysis. Finally, ultra-performance liquid chromatography-tandem mass spectrometry is employed for label-free analysis of the EV proteome. This protocol thus provides a comprehensive approach to study and use plasma-derived EV as potential carriers of critical biological information as well as to explore their potential as novel biomarkers.

Introduction

Extracellular vesicles (EV), by nomenclature not uniformly defined, are nanoparticles surrounded by a lipid bilayer and released by various cell types, lacking the ability to replicate1. This diverse group includes exosomes, a subpopulation of EV of endosomal origin, typically ranging from approximately 40 nm to 160 nm in diameter2. Detectable in numerous body fluids3, EVs facilitate intercellular communication by transferring various active biomolecules such as proteins, mRNA, microRNA, and lipids. Thus, EV provide information about their cell of origin through cell-specific surface markers and b....

Protocol

For this protocol, an exemplary patient cohort was recruited comprising three healthy control patients with no signs of apparent or underlying cardiovascular disease and two patients with non-ST elevated myocardial infarction (NSTEMI). Prior approval was granted by the Institutional Review Board of the Medical Faculty of the University of Heidelberg (IRB approval #S-351/2015), and written consent was obtained from all patients prior to recruitment. Patients were recruited from the Chest Pain Unit of the Department of Car.......

Representative Results

EV were isolated from plasma samples (n = 3) of patients without overt cardiovascular disease, as well as from patients with non-ST elevation myocardial infarction (NSTEMI; n = 2), using the established differential ultracentrifugation protocol. Adequate separation of plasma EV was confirmed by immunoblotting of EV-enriched proteins TSG-101, annexin 5 (Anx5), and CD9 in EV isolates compared to EV-depleted plasma from the same patients (Figure 1A). Transferrin, serving as a negative control, .......

Discussion

This protocol provides a real-world, step-by-step, ready-to-use methodology for the separation and characterization of plasma EV, as well as an introduction to an unlabeled proteome analysis suitable for integration into routine clinical practice. A detailed description and strict adherence to a unified methodology for EV isolation from plasma samples are important to ensure reproducibility of obtained results. Current literature indicates that pre-analytical conditions can significantly impact subsequent measurements an.......

Disclosures

EG received honoraria for lecturers from Roche Diagnostics, BRAHMS Thermo Scientific, Bayer Vital GmbH, AstraZeneca, Lilly Deutschland, Boehringer Ingelheim; he received institutional research grants from Roche Diagnostics and Daiichi Sankyo, and serves as a consultant for Roche Diagnostics, BRAHMS Thermo Scientific, Astra Zeneca, Novartis and Boehringer Ingelheim, outside the submitted work. JBK received project-related funding from the German Centre for Cardiovascular Research (DZHK) and Roche Diagnostics. The remaining authors declare no conflict of interest related to the submitted work.

Acknowledgements

The authors thank Heidi Deigentasch, Amelie Werner, and Elisabeth Mertz for their organizational support during this project.

....

Materials

NameCompanyCatalog NumberComments
4x Laemmli sample buffferBio-rad1610747
10x RIPA-BufferAbcamab156034
26.3 mL Polycarbonate Bottle with Cap Assembly for UltracentrifugationBeckman Coulter355654
5810R Benchtop centrifugeEppendorf5811000015
Acetonitrile (ACN)Biosolve0001204101BS
Dithiothreitol (DTT)Sigma-Aldrich43816-10ML
Dulbecco's Phosphate buffered saline (PBS)Sigma-AldrichD8537
Formic Acid 99% ULC/MS 100Biosolve0006914143BS
Histopaque - 1077Sigma-Aldrich10771
Iodoacetamide (IAA)Sigma-AldrichI6125-5G
Mass Spectrometer Orbitrap Q Exactive HFThermo Fisher ScientificIQLAAEGAAPFALGMBDK
MOPS SDS running bufferThermo FisherB0001
NanoSight NS300Malvern Panalytical NS300
Nanosight NTA 3.2 SoftwareMalvern Panalytical 
NuPAGE 4 bis 12 %, Bis-Tris protein gelsInvitrogenNP0323
Optima XPN-80 floor-standing ultracentrifugeBeckman Coulter521-4180
PageRuler Plus Prestained Protein LadderThermo Fisher Scientific26619
Protease/Phosphatase Inhibitor Cocktail (100X)Cell Signaling Technology5872S
Protein markerThermo Fisher26616
Proteome Discoverer 2.5Thermo Fisher
Q Exactive Plus Hybrid Quadrupole-Orbitrap Mass SpectrometerThermo Fisher ScientificIQLAAEGAAPFALGMBDK
Quick stain coomasssieServa35081.01
ReproSil-Pur 120 C18-AQ, 1.9 µm 1 gDr. Maischr119.aq.0001
SDS-PAGE commercial gelThermo FisherNW00100BOX
S-Monovette Citrat 9NC 0.106 mol/l 3,2%Sarstedt02.1067.001
Speed vac concentratorSavant
Swiss-Prot (Uniprot) Homo sapiens (UP000005640, June 2020) protein databaseUniProthttps://www.uniprot.org/proteomes/UP000005640
Triethylammonium bicarbonate buffer (TEAB)Sigma-AldrichT7408
Trifluoroacetic acid (TFA) for HPLC >99%, 100 mLSigma-Aldrich302031-100ML
Trypsin MS-GradeThermo Fisher90058
Type 50.2 Ti Fixed-Angle RotorBeckman Coulter337901
UHPLC Dionex Ultimate 3000Thermo Fisher ScientificULTIM3000RSLCNANO
WaterBiosolve0023214102BS

References

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

MedicineExtracellular vesiclesproteomicsdifferential centrifugationnanoparticle tracking analysisliquid chromatography tandem mass spectrometry

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved